ArriVent BioPharma, Inc.

Historical 13F Holders

Symbol
AVBP
CUSIP
04272N102
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 04272N102 since 12/18/2024, largest first.

Filer % of Class Filed
Infinitum Asset Management, LLC 13G/A
9.9% 2/17/2026
Event 12/31/2025
Suvretta Capital Management, LLC 13G/A
9.9% 8/13/2025
Event 6/30/2025
Hillhouse Investment Management, Ltd. 13G/A 9.5% 2/17/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 6.8% 7/27/2026
Event 6/30/2026
Orbimed Advisors LLC 13D/A
5.8% 10/8/2026
Event 10/6/2026
FMR LLC 13G/A
5.8% 11/5/2026
Event 9/30/2026
HBM Healthcare Investments (Cayman) Ltd. 13G 5.4% 10/15/2025
Event 10/8/2025
Vivo Opportunity Fund Holdings, L.P. 13G
5.0% 10/13/2026
Event 10/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Octagon Capital Advisors LP 13G/A
4.9% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 4.5% 1/30/2026
Event 12/31/2025
Sofinnova Venture Partners IX, L.P. 13G/A
4.1% 3/5/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 156 50.5 M $1.53B
2026 Q2 159 46.1 M $1.60B
2026 Q1 140 42.1 M $969M
2025 Q4 124 40.1 M $810M
2025 Q3 107 38.6 M $712M
2025 Q2 100 33.6 M $732M
2025 Q1 84 29.1 M $539M
2024 Q4 81 28.5 M $757M
2024 Q3 69 25.9 M $612M
2024 Q2 55 21.7 M $404M
2024 Q1 54 21.9 M $389M